Stockreport

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2020

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Company Announcement Net sales of DARZALEX® in the first quarter of 2020 totaled USD 937 millionGenmab will receive royalties on worldwide sales from Janssen Biotech, I [Read more]